CISA list

As of , CVE-2026-123218 in IBM Aspera Faspex is on CISA's list of exploited vulnerabilities: CISA listed it on . Our patch-first group: Patch now.

CVE-2026-123218

IBM Aspera Faspex: Incorrect Authorization. Exploited, and in our Patch now group.

Our patch-first group

Patch now

  • Forensic triage required by CISA
  • Listed in the last 14 days

CISA's required action

Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.

Patch infofixed versions and vendor advice

What to install

  • Affects IBM Aspera Faspex from 5.0.0 up to and including 5.0.19.

    The record's list of affected products names no fixed version.

Vendor advice

Vendor advice: www.ibm.com, from CISA's entry.

EPSS score
0.01
Higher than 64% of the CVEs EPSS scores.

EPSS estimates the chance of exploitation activity in the next 30 days.

Exploited
Yes CISA listed it on 9 November 2026
US federal deadline
12 November 2026 3 days after CISA listed it. US federal civilian agencies must fix it by then.
Used in ransomware campaigns
Not known to CISA
EPSS when listed
0.00 on 9 November 2026 EPSS on the day CISA listed it.
Public exploit
None found Neither Metasploit nor Exploit-DB lists one.

Since listing

EPSS since listing

0.000.501.000.50: EPSS line for Patch this weekListed by CISA0.000.501.00Listed by CISA

EPSS for CVE-2026-123218 since CISA listed it, on the days its value to 2 decimals changed. EPSS scores by FIRST.

Show the numbers
FromEPSS
0.00
0.01

Timeline

What happened when

  1. The CVE record was published.
  2. CISA added it to its list of exploited vulnerabilities.
  3. The US federal deadline to fix it.

CISA's required action

What CISA says to do

Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.

Agencies must also look for signs that attackers already got in.

Read further: CISA's catalog

The flaw

What the flaw is

IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.

CISA's description

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

The CVE record's description, from ibm

CVE published
7 November 2026
Assigned by
ibm
CVSS
9.8 Critical (CVSS 3.1, from the CNA)
CWE-863
Incorrect Authorization
CISA SSVC, exploitation
active
CISA SSVC, automatable
yes
CISA SSVC, technical impact
total

Same product

Aspera Faspex: other exploited entries

Other exploited Aspera Faspex entries
VulnerabilityProductOur groupListedDeadlineEPSS
CVE-2022-47986Code ExecutionAspera FaspexPatch this weekRansomwareDue0.99
Sources
  • CVE records: Copyright © 1999-2026, The MITRE Corporation. CVE is a trademark and the CVE logo is a registered trademark of The MITRE Corporation (source). Licence: CVE Program Terms of Use
  • CWE names: Copyright © 2006-2026, The MITRE Corporation. CWE, CWSS, CWRAF, and the CWE logo are trademarks of The MITRE Corporation (source). Licence: CWE Terms of Use
  • EPSS scores by FIRST (https://www.first.org/epss/), generated by Empirical Security (source)